PD-1-inhibitor pembrolizumab for treatment of progressive multifocal leukoencephalopathy

Nora Möhn, Mike P. Wattjes, Ortwin Adams, Sandra Nay, Daria Tkachenko, Friederike Salge, Johanne Heine, Kaweh Pars, Günter Höglinger, Gesine Respondek, Martin Stangel, Thomas Skripuletz, Roland Jacobs, Kurt-Wolfram Sühs

Open source

DOI: 10.1177/1756286421993684
Published: 2021-01
Container: Therapeutic Advances in Neurological Disorders
Publisher: SAGE Publications
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1177/1756286421993684,
  title = {PD-1-inhibitor pembrolizumab for treatment of progressive multifocal leukoencephalopathy},
  author = {Nora Möhn and Mike P. Wattjes and Ortwin Adams and Sandra Nay and Daria Tkachenko and Friederike Salge and Johanne Heine and Kaweh Pars and Günter Höglinger and Gesine Respondek and Martin Stangel and Thomas Skripuletz and Roland Jacobs and Kurt-Wolfram Sühs},
  year = {2021},
  journal = {Therapeutic Advances in Neurological Disorders},
  doi = {10.1177/1756286421993684},
  url = {https://doi.org/10.1177/1756286421993684}
}

RIS

TY  - JOUR
TI  - PD-1-inhibitor pembrolizumab for treatment of progressive multifocal leukoencephalopathy
AU  - Nora Möhn
AU  - Mike P. Wattjes
AU  - Ortwin Adams
AU  - Sandra Nay
AU  - Daria Tkachenko
AU  - Friederike Salge
AU  - Johanne Heine
AU  - Kaweh Pars
AU  - Günter Höglinger
AU  - Gesine Respondek
AU  - Martin Stangel
AU  - Thomas Skripuletz
AU  - Roland Jacobs
AU  - Kurt-Wolfram Sühs
PY  - 2021
JO  - Therapeutic Advances in Neurological Disorders
DO  - 10.1177/1756286421993684
UR  - https://doi.org/10.1177/1756286421993684
ER  -

APA

Möhn, N., Wattjes, M. P., Adams, O., Nay, S., Tkachenko, D., Salge, F., Heine, J., Pars, K., Höglinger, G., Respondek, G., Stangel, M., Skripuletz, T., Jacobs, R., & Sühs, K. (2021). PD-1-inhibitor pembrolizumab for treatment of progressive multifocal leukoencephalopathy. Therapeutic Advances in Neurological Disorders. https://doi.org/10.1177/1756286421993684

Source records

crossref · retrieved 2026-11-10T11:03:52.232Z